Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"NBD1"”.
-
The CFTR Folding Pathway: Implications for the Identification and Development of CF Therapeutics
… F508 is located in Nucleotide Binding Domain 1 (NBD1) and is predicted to be at the interface with Intracellular Loop 4 (ICL4) of Transmembrane Domain 2 (TMD2). Studies of the isolated NBD1 demonstrate that the ΔF508 mutation impacts the folding pathway and stability of the domain. Misfolding of …
-
Structural Characterization and Interactions of the CFTR Regulatory Region
… R region of CFTR and its interactions with NBD1 and SLC26A3 STAS have been characterized at residue-specific resolution, primarily using NMR. Limited chemical shift dispersion indicates that the R region is intrinsically disordered in solution and that no global folding event occurs upon …
-
Molecular Level Analysis of Disease-causing Mutations in the Sulfonylurea Receptor One
… domains and two nucleotide binding domains (NBD1 and NBD2). Short helices, termed coupling helices, connect the long helical extensions in the membrane domains and contact the NBDs. MgATP binding and hydrolysis at the SUR1 NBDs result in KATP channel opening. Mutations of the SUR1 NBDs or the …
-
Structural and Mechanistic Insights into the Yeast Disaggregase Hsp104
… an interface with nucleotide binding domain 1 (NBD1) and the middle domain (MD). We discovered a loop in NBD1 that may engage substrate in the ADP bound state to prevent premature substrate release, identified the region of the MD (helix 2) responsible and the mechanism of signal transmission …
-
Biophysical Studies of the First Nucleotide Binding Domain of Sulfonylurea Receptor 2A to Assess the Significance of Phosphorylation and Mutations
… level information on the conformation of SUR2A NBD1. These studies enabled us to investigate the structural, dynamic and functional effects of phosphorylation, disease-causing mutations and drug binding in NBD1. Our data suggest that SUR2A NBD1 contains a number of disordered loops that may …
-
Domain interactions and structural cooperativity in two classes of drug targets investigated by differential scanning calorimetry: I. ABC transporters: cystic fibrosis transmembrane conductance regulator and P-glycoprotein; II. Bacillus subtilis NAD+synthetase.
… in its N-terminal nucleotide binding domain (NBD1), which causes CFTR misfolding and premature degradation. By studying the in vitro thermal unfolding of the isolated NBD1 ± F508del using differential scanning calorimetry (DSC), we show that F508del significantly reduces the thermodynamic and …
-
Structure-Function Studies on Human Epithelial Cystic Fibrosis Chloride Channels Expressed in Xenopus Laevis Oocytes
… domains, two nucleotide binding domains (NBD1, NBD2) and a regulatory (R) domain. Channel gating is controlled by R-domain phosphorylation and by ATP binding and/or hydroysis at the NBDs. Exon 13 of the CFTR gene encodes residues 590 to 830, originally ascribed to the R domain. Here, CFTR …
-
Structural and Biochemical Characterization of the Effects of Post-Translational Modifications in the Regulation of ATP-Binding Cassette Proteins
… binding domains (NBDs) arranged as TMD0-TMD1-NBD1-TMD2-NBD2. Ycf1p also contains the cytoplasmic loop (L0), which connects TMD0 to TMD1, and an intrinsically disordered regulatory (R) region that links NBD1 to TMD2. The activity of Ycf1p and almost all ABC proteins is regulated through …
-
The Role of the Di-arginine "R553AR555" Motif in Modulating Trafficking and Function of the Major Cystic Fibrosis Causing Mutant (DeltaF508-CFTR)
… in the first nucleotide binding domain (NBD1) rescues the trafficking defect of ΔF508-CFTR. We hypothesized that if the R553AR555 motif mediates retention of the ΔF508-CFTR protein, peptides that mimic this motif should antagonize mistrafficking mediated by aberrant exposure of the …
-
Examination Of The Dynamic Assembly Mechanism Of E. Coli Clpa
… contains two nucleotide binding domains, NBD1 and NBD2. Recently, our lab applied hydrodynamic techniques to quantify the self-assembly mechanism of a closely related AAA+ chaperone, E. coli ClpB. Here we apply the techniques and analysis from that work to investigate the nucleotide-linked …
-
A Hierarchical Graph for Nucleotide Binding Domain 2
… namely, the nucleotide binding domain 1 (NBD1). However, some mutations in nucleotide binding domain 2 (NBD2) can equally cause cystic fibrosis. In this work, a hierarchical graph is built for NBD2. Using this model for NBD2, we examine the consequence of single point mutations on NBD2. We …
-
The CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Channel: Anion Permeation, and Regulation by Adenylyl Cyclase and ATP Hydrolysis
… channels can bind and hydrolyze ATP only at NBD1, resulting in exclusively brief channel openings. Fully phosphorylated channels can bind and hydrolyze ATP at both NBD1 and NBD2: hydrolysis at NBD1 opens channels, and binding of ATP at NBD2 stabilizes the channel in the open conformation, …
-
CFTR chloride channels and ABC active transporters undergo similar structural rearrangements as part of their operation
… two cytosolic nucleotide-binding domains (NBD1 and NBD2), two transmembrane domains (TMD1 and TMD2) and a regulatory (R) domain. Here, I adopted the cysteine scanning method to study two transmembrane segments (TM6 and TM12) of CFTR. Major findings are that (i) like other ABC proteins, both …
-
Structural Basis for Misfolding at Disease Phenotypic Positions in CFTR
… in the soluble nucleotide binding domain 1 (NBD1) of CFTR. We found that mutations can have a significant effect on thermodynamic stability that is masked in non-physiological conditions. Our studies were then focussed on a membrane-embedded hairpin CFTR fragment comprised of transmembrane …
-
CFTR gating mechanism : the role of dimerization of nucleotide binding domains
… NBD2 site, and tighter binding at W401 at the NBD1 site prolongs channel open time. We then studied the role of signature sequence in channel gating. We found that micromolar [Cd2+] can dramatically increase the activity of G551D-CFTR. A specific region of the signature sequence is found to …
-
Employing the Use of Molecular Dynamics to Explore Protein Stability and Optimize Free Energy Protocols
… were then tested experimentally using ΔF508- NBD1 expressed in E. coli. DSF experiments were conducted, ultimately revealing that two of the tested small molecules binds to our protein, but showing destabilizing effects rather than the stabilizing effects we’d hoped to see. In Chapter 3, MD …
-
The regions connecting the membrane spanning and nucleotide binding domains of MRP1 are functionally distinct
… bind and hydrolyze ATP. MSD1/2 are linked to NBD1/2 by connecting regions (CR) 1 (aa 600-642) and CR2 (aa 1249-1291), respectively. To test the hypothesis that the CRs are functionally distinct, eight CR residues (four in CR1: S612A, R615A, H622A, E624A and four in CR2: T1270A, P1275A, W1287A, …
-
Application of Cysteine Scanning Mutagenesis to the Multidrug Resistance Protein (MRP)1
… of cysteines on juxtaposed faces of the NBD1:NBD2 heterodimer at positions 775 and 1329; comparable residues in the related Cystic Fibrosis Transmembrane Regulator (CFTR/ABCC7) have been suggested to be evolutionarily coupled and joined by a hydrogen bond, maintained in structures of …
-
Reverting the F508del-CFTR defect in Cystic Fibrosis with CRISPR-Cas technology
… located in the nucleotide-binding domain 1 (NBD1). F508del is a three-nucleotide deletion that results in the loss of a phenylalanine at position 508 in the protein and in the consequent CFTR degradation by the ubiquitin-proteasome system. Different attempts to correct F508del-CFTR gene were …
-
Potentiated Hsp104 Variants Suppress The Toxicity Of Most Overexpressed Dosage-Sensitive Yeast Genes
… channel of Hsp104. Moreover, ATPase activity at NBD1 or NBD2 was required for Hsp104A503S to alleviate toxicity of dosage-sensitive genes. Rescue of toxicity by Hsp104A503S was not typically due to decreases in toxic protein expression or disaggregation of amyloid. In addition, neither autophagy …
Page 1 of 2